Recruiting OBSERVATIONAL NCT06660121

Electrochemotherapy for Desmoid Tumors (ECT-DESMO)

Treatment of Desmoid Fibromatosis With Electrochemotherapy. Prospective Observational Study

Sponsor: Istituto Ortopedico Rizzoli

Interventions Electrochemotherapy with bleomycin

Updated 3 times since 2024 Last updated: Dec 22, 2025 Started: Oct 17, 2024 Primary completion: Aug 1, 2028 Completion: Aug 1, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Desmoid Fibromatosis, this trial is actively recruiting participants. The trial is conducted by Istituto Ortopedico Rizzoli and has accumulated 3 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Jan 2026 — Present [monthly]

Recruiting
Dec 2024 — Jan 2026 [monthly]

Recruiting
Nov 2024 — Dec 2024 [monthly]

Recruiting

First recorded

Oct 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istituto Ortopedico Rizzoli

Data source: Istituto Ortopedico Rizzoli

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bologna, Italy